An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

May 27, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
Bladder Urothelial Cancer
Interventions
DRUG

ICP-192

ICP-192 is a white, round, uncoated table

Trial Locations (22)

100035

RECRUITING

Peking University First Hospital, Beijing

100071

RECRUITING

The fifth Medical Center of People's Liberation Army General Hospital, Beijing

100142

RECRUITING

Beijing Cancer Hospital, Beijing

110801

RECRUITING

Liaoning Cancer Hospital & Institute, Shenyang

130021

RECRUITING

The First Hospital of JiLin University, Jilin

150081

RECRUITING

Harbin Medical University Cancer Hospital, Harbin

200025

RECRUITING

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

215006

RECRUITING

The First Affiliated Hospital of Suzhou University, Suzhou

230000

RECRUITING

The First Affiliated Hospital of Anhui Medical University, Hefei

250012

RECRUITING

Shandong University Qilu Hospital, Jinan

300060

RECRUITING

Tianjin Medical University Cancer Institute & Hospital, Tianjin

300211

RECRUITING

The Second Hospital of Tianjin Medical University, Tianjin

310003

RECRUITING

The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

310014

RECRUITING

Zhejiang Provincial People's Hospital, Hangzhou

310022

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

400016

RECRUITING

The First Affiliated Hospital of Chongqing Medical University, Chongqing

410013

RECRUITING

Hunan Cancer Hospital, Changsha

430022

RECRUITING

Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan

430030

RECRUITING

Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan

610000

RECRUITING

Sichuan Cancer Hospital, Chengdu

730030

RECRUITING

Lanzhou University Second Hospital, Lanzhou

030001

RECRUITING

First Hospital of Shanxi Medical University, Taiyuan

All Listed Sponsors
lead

Beijing InnoCare Pharma Tech Co., Ltd.

INDUSTRY